Publications by authors named "Aliza Asif"
Semin Arthritis Rheum
December 2024
Article Synopsis
- Abatacept, a biological DMARD, shows promise in preventing rheumatoid arthritis (RA) in high-risk individuals based on a meta-analysis of three randomized controlled trials involving 367 participants.
- The analysis indicates that abatacept significantly lowers the risk of developing RA and improves joint tenderness and functional disability, although it does not significantly reduce pain.
- The safety profile of abatacept is favorable, with no major differences in adverse events compared to a placebo; however, further long-term studies are needed to confirm these results.
